172 related articles for article (PubMed ID: 23335742)
1. In vitro antifungal susceptibility of clinically relevant species belonging to Aspergillus section Flavi.
Gonçalves SS; Stchigel AM; Cano J; Guarro J; Colombo AL
Antimicrob Agents Chemother; 2013 Apr; 57(4):1944-7. PubMed ID: 23335742
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
Wang HC; Hsieh MI; Choi PC; Wu CJ
J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of amphotericin B, terbinafine, and azole drugs against clinical and environmental isolates of Aspergillus terreus sensu stricto.
Fernández MS; Rojas FD; Cattana ME; Sosa Mde L; Iovannitti CA; Lass-Flörl C; Giusiano GE
Antimicrob Agents Chemother; 2015; 59(6):3619-22. PubMed ID: 25824228
[TBL] [Abstract][Full Text] [Related]
4. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
Öz Y; Özdemir HG; Gökbolat E; Kiraz N; Ilkit M; Seyedmousavi S
Mycopathologia; 2016 Apr; 181(3-4):225-33. PubMed ID: 26612621
[TBL] [Abstract][Full Text] [Related]
5. Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait.
Al-Wathiqi F; Ahmad S; Khan Z
BMC Infect Dis; 2013 Mar; 13():126. PubMed ID: 23496810
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
Badali H; Fakhim H; Zarei F; Nabili M; Vaezi A; Poorzad N; Dolatabadi S; Mirhendi H
Mycopathologia; 2016 Apr; 181(3-4):235-40. PubMed ID: 26615417
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activities of terbinafine, itraconazole and amphotericin B against Aspergillus and Cladosporium species.
Kantarcioğlu AS; Yucel A
J Chemother; 2002 Dec; 14(6):562-7. PubMed ID: 12583546
[TBL] [Abstract][Full Text] [Related]
9. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
Pfaller MA; Messer SA; Hollis RJ; Jones RN;
Antimicrob Agents Chemother; 2002 Apr; 46(4):1032-7. PubMed ID: 11897586
[TBL] [Abstract][Full Text] [Related]
10. Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods.
Espinel-Ingroff A; Abreu DPB; Almeida-Paes R; Brilhante RSN; Chakrabarti A; Chowdhary A; Hagen F; Córdoba S; Gonzalez GM; Govender NP; Guarro J; Johnson EM; Kidd SE; Pereira SA; Rodrigues AM; Rozental S; Szeszs MW; Ballesté Alaniz R; Bonifaz A; Bonfietti LX; Borba-Santos LP; Capilla J; Colombo AL; Dolande M; Isla MG; Melhem MSC; Mesa-Arango AC; Oliveira MME; Panizo MM; Pires de Camargo Z; Zancope-Oliveira RM; Meis JF; Turnidge J
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739796
[TBL] [Abstract][Full Text] [Related]
11. Molecular identification and antifungal susceptibility of clinically relevant and cryptic species of
Nargesi S; Jafarzadeh J; Najafzadeh MJ; Nouripour-Sisakht S; Haghani I; Abastabar M; Ilkit M; Hedayati MT
J Med Microbiol; 2022 Apr; 71(4):. PubMed ID: 35451946
[No Abstract] [Full Text] [Related]
12. MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp.
Schmitt HJ; Bernard EM; Andrade J; Edwards F; Schmitt B; Armstrong D
Antimicrob Agents Chemother; 1988 May; 32(5):780-1. PubMed ID: 3134851
[TBL] [Abstract][Full Text] [Related]
13. In vitro antifungal susceptibility of clinical species belonging to Aspergillus genus and Rhizopus oryzae.
Kachuei R; Khodavaisy S; Rezaie S; Sharifynia S
J Mycol Med; 2016 Mar; 26(1):17-21. PubMed ID: 26852191
[TBL] [Abstract][Full Text] [Related]
14. In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex.
Vaezi A; Fakhim H; Arastehfar A; Shokohi T; Hedayati MT; Khodavaisy S; Rezaei-Matehkolaei A; Badiee P; Hagen F; Lass-Flörl C; Dannaoui E; Meis JF; Badali H
Mycoses; 2018 Feb; 61(2):134-142. PubMed ID: 29064123
[TBL] [Abstract][Full Text] [Related]
15. Species Identification and
Imbert S; Normand AC; Ranque S; Costa JM; Guitard J; Accoceberry I; Bonnal C; Fekkar A; Bourgeois N; Houzé S; Hennequin C; Piarroux R; Dannaoui E; Botterel F
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439956
[No Abstract] [Full Text] [Related]
16. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.
Ryder NS; Leitner I
Med Mycol; 2001 Feb; 39(1):91-5. PubMed ID: 11270414
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.
Arikan S; Sancak B; Alp S; Hascelik G; McNicholas P
Med Mycol; 2008 Sep; 46(6):567-73. PubMed ID: 19180726
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
Badali H; Mohammadi R; Mashedi O; de Hoog GS; Meis JF
Mycoses; 2015 May; 58(5):303-7. PubMed ID: 25757042
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory and fungicidal effects of antifungal drugs against Aspergillus species in the presence of serum.
Elefanti A; Mouton JW; Krompa K; Al-Saigh R; Verweij PE; Zerva L; Meletiadis J
Antimicrob Agents Chemother; 2013 Apr; 57(4):1625-31. PubMed ID: 23318807
[TBL] [Abstract][Full Text] [Related]
20. Comparative Evaluation of Sensititre YeastOne and CLSI M38-A2 Reference Method for Antifungal Susceptibility Testing of Aspergillus spp. against Echinocandins.
Siopi M; Pournaras S; Meletiadis J
J Clin Microbiol; 2017 Jun; 55(6):1714-1719. PubMed ID: 28330883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]